Finch Therapeutics Group, Inc. (FNCH)

NASDAQ: FNCH · IEX Real-Time Price · USD

2.300

-0.480 (-17.27%)

At close: Apr 24, 2024, 3:59 PM

2.390

+0.090 (3.91%)

After-hours: Apr 24, 2024, 7:54 PM EDT

Finch Therapeutics Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	4	6	23	473	-
Market Cap Growth	-	-74.79%	-95.14%	-	-
Enterprise Value	9	11	4	346	-98
PE Ratio	-0.08	-0.08	-0.20	-8.14	-
PS Ratio	34.52	54.18	26.70	25.54	-
PB Ratio	0.16	0.25	0.24	2.34	-
P/FCF Ratio	-0.19	-0.19	-0.30	-5.70	-
P/OCF Ratio	-0.18	-0.18	-0.31	-7.05	-
EV/Sales Ratio	81.26	100.92	4.98	18.66	-12.68
EV/EBITDA Ratio	-0.14	-0.14	-0.04	-6.19	2.54
EV/EBIT Ratio	-0.14	-0.14	-0.04	-5.95	2.49
EV/FCF Ratio	-0.36	-0.36	-0.06	-4.16	2.88
Debt / Equity Ratio	1.32	1.32	0.55	0.03	-0.02
Debt / EBITDA Ratio	-0.40	-0.40	-0.49	-0.11	-0.05
Debt / FCF Ratio	-1.00	-1.00	-0.68	-0.07	-0.05
Quick Ratio	6.15	6.15	4.85	9.06	8.78
Current Ratio	6.33	6.33	5.08	9.64	9.24
Asset Turnover	0.00	0.00	0.00	0.08	0.06
Return on Equity (ROE)	-273.00%	-273.00%	-82.60%	-26.10%	50.70%
Return on Assets (ROA)	-114.70%	-114.70%	-58.50%	-23.90%	-29.30%
Return on Capital (ROIC)	-158.19%	-158.19%	-78.08%	-28.81%	41.99%
Earnings Yield	-2024.07%	-1289.57%	-498.66%	-12.29%	-
FCF Yield	-817.11%	-520.60%	-335.06%	-17.55%	-
Buyback Yield / Dilution	-0.94%	-0.94%	-21.65%	-381.31%	-11.64%
Total Shareholder Return	-0.94%	-0.94%	-21.65%	-381.31%	-11.64%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).